enow.com Web Search

  1. Ads

    related to: pediatric rheumatoid arthritis treatment medication

Search results

  1. Results from the WOW.Com Content Network
  2. Childhood arthritis - Wikipedia

    en.wikipedia.org/wiki/Childhood_arthritis

    Childhood arthritis (juvenile arthritis or pediatric rheumatic disease) is an umbrella term used to describe any rheumatic disease or chronic arthritis-related condition which affects individuals under the age of 16. There are several subtypes that differentiate themselves via prognosis, complications, and treatments.

  3. Juvenile idiopathic arthritis - Wikipedia

    en.wikipedia.org/wiki/Juvenile_idiopathic_arthritis

    Juvenile idiopathic arthritis (JIA), formerly known as juvenile rheumatoid arthritis (JRA), [1] is the most common chronic rheumatic disease of childhood, affecting approximately 3.8 to 400 out of 100,000 children. [3]

  4. Systemic-onset juvenile idiopathic arthritis - Wikipedia

    en.wikipedia.org/wiki/Systemic-onset_juvenile...

    According to estimates, juvenile idiopathic arthritis (JIA) affects 1 to 4 out of every 1000 children, making it the most prevalent rheumatic illness in children. [ 34 ] [ 35 ] With incidence rates ranging from 0.4 to 0.8 children per 100,000 children, sJIA accounts for 10% to 20% of JIA cases.

  5. Tocilizumab - Wikipedia

    en.wikipedia.org/wiki/Tocilizumab

    Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).

  6. Antiarthritics - Wikipedia

    en.wikipedia.org/wiki/Antiarthritics

    Conventional DMARDs are known to be the first-line treatment for rheumatoid arthritis. [9] Treatment can be a monotherapy or in combination with other anti-arthritic medications. Common DMARDs include oral methotrexate, leflunomide, or sulfasalazine. Conventional DMARDs have a slow onset of action and can take 2–3 months to exhibit effect. [9]

  7. Adalimumab - Wikipedia

    en.wikipedia.org/wiki/Adalimumab

    Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

  1. Ads

    related to: pediatric rheumatoid arthritis treatment medication